FDA Issues: Review & Approval of New Drugs & Other Regulatory Issues

New HIV Drug Dolutegravir Could Soon Be Approved by FDA (February 28, 2013)
From TheBodyPRO.com
What's a Fulyzaq? I Thought You'd Never Ask (January 3, 2013)
From Journal Watch
Food and Drug Administration Urged to Speed Approval of Drugs (September 26, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
FDA Approval of Generic ARVs (July/August 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
More Than 150 Antiretroviral Drugs Available Through PEPFAR for Worldwide HIV/AIDS Relief (July 23, 2012)
From U.S. Food and Drug Administration
Advocates, Policy Experts Respond to FDA Approval of Truvada for HIV Prevention (July 17, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Truvada Approved to Reduce the Risk of Sexually Transmitted HIV in People Who Are Not Infected With the Virus (July 16, 2012)
From U.S. Food and Drug Administration
New In-Home HIV Test Raises Follow-Up Concerns (July 6, 2012)
In Kaiser Daily Health Policy Report, from Henry J. Kaiser Family Foundation
FDA Approves at-Home HIV Test, Available in October (July 5, 2012)
In Kaiser Daily Health Policy Report, from Henry J. Kaiser Family Foundation
First In-Home, Rapid HIV Antibody Test Approved for Use in U.S. (July 3, 2012)
From U.S. Food and Drug Administration

VIEW ALL ARTICLES

MOST VIEWED ARTICLES

	HIV Management Today: Mental Health & HIV, the Uncharted Territory
	Danish Study Targets HIV Reservoir, in Latest Search for HIV Cure
	10 Top Studies Whose Impact Will Last Well Beyond CROI 2013
	CROI 2013: Women's Issues in HIV Research (Video)
	HIV Opportunistic Infection Guidelines Updated
	PrEP Failures and Successes: One Study Whose Impact Will Last Well Beyond CROI 2013

More Most Viewed Articles

TheBodyPRO.com is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.